Drug Profile
Research programme: peginterferon beta-1b - Nuron
Alternative Names: Long-acting inteferon beta-2b - Nuron; NU 400Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Nuron Biotech
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunomodulators; Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Multiple sclerosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Multiple-sclerosis in USA (Parenteral)
- 13 Dec 2011 Nuron exercises its option for an exclusive worldwide licence to PolyTherics' TheraPEG™ technology
- 27 May 2011 Preclinical trials in Multiple sclerosis in USA (Parenteral)